IRIS - Res&Arch Institutional Research Information System - Research & Archive

MILANO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 643
EU - Europa 405
AS - Asia 284
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
OC - Oceania 1
Totale 1.337
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 643
IE - Irlanda 156
IT - Italia 153
SG - Singapore 110
HK - Hong Kong 63
VN - Vietnam 48
CN - Cina 43
RU - Federazione Russa 19
FR - Francia 14
SE - Svezia 12
FI - Finlandia 10
KR - Corea 10
UA - Ucraina 10
DE - Germania 8
TR - Turchia 7
AT - Austria 4
GB - Regno Unito 4
PL - Polonia 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EU - Europa 3
BE - Belgio 2
GR - Grecia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
QA - Qatar 1
UZ - Uzbekistan 1
Totale 1.337
Salva come PNG Salva come JPEG
Città #
Dublin 156
Chandler 135
Singapore 96
San Mateo 74
Hong Kong 63
Perugia 63
Dong Ket 47
Boardman 46
Santa Clara 38
Medford 29
Princeton 27
Lawrence 26
Pisa 26
Redmond 17
Wilmington 17
Altamura 16
Des Moines 15
Andover 14
Beijing 14
Rome 11
Seoul 10
Saint Petersburg 8
San Paolo di Civitate 8
Dallas 7
Helsinki 7
Izmir 7
Florence 5
Norwalk 5
Los Angeles 4
Munich 4
Olomouc 3
Vienna 3
Arezzo 2
Brussels 2
Gradara 2
New York 2
Padova 2
Redwood City 2
Abidjan 1
Acireale 1
Ann Arbor 1
Ashburn 1
Civitanova Marche 1
Copenhagen 1
Dearborn 1
Foligno 1
Frankfurt Am Main 1
Fremont 1
Jinan 1
Kiev 1
Moscow 1
Nuremberg 1
Piscataway 1
San Diego 1
Shanghai 1
Shijiazhuang 1
Sydney 1
Todi 1
Woodbridge 1
Totale 1.034
Salva come PNG Salva come JPEG
Nome #
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 128
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 109
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 84
Mutant NPM1 Maintains the Leukemic State through HOX Expression 66
Germline GATA2 variant disrupting endothelial eNOS cell function and angiogenesis can be restored by c-Jun/AP-1 upregulation 58
CD123 (IL-3R alpha) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION 57
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 57
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 53
Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens 47
Low level of Her-2 locus amplification by fluorescent in situ hybridization does not correlate with Her-2 protein overexpression by immunohistochemistry in Barrett's esophagus 47
Bone Morphogenetic Protein 4 Expressed in Esophagitis Induces a Columnar Phenotype in Esophageal Squamous Cells 46
An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes 45
Cytokeratin and CDX-2 expression in Barrett's esophagus 43
microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients 42
Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery 40
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 39
An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer 38
A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia 38
Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardia 37
Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus 35
Expression pattern of immune suppressive cytokines and growth factors in oesophageal adenocarcinoma reveal a tumour immune escape-promoting microenvironment 33
Electroporation of dendritic cells with autologous total RNA from tumor material 33
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells 32
Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population 31
A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia 30
Gene expression profile comparison of Barrett's esophagus epithelial cell cultures and biopsies 29
Current status and future perspectives in targeted therapy of NPM1-mutated AML 28
Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response 25
Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine 23
SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their Combinations 22
Novel therapeutic strategies for treating esophageal adenocarcinoma: The potential of dendritic cell immunotherapy and combinatorial regimens 20
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 13
Inhibition of the BMP pathway prevents development of Barrett's-associated adenocarcinoma in a surgical rat model 11
Totale 1.439
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.529
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 1 0 2 1 11 5 0
2020/2021191 0 0 0 0 86 3 0 19 31 2 0 50
2021/2022241 11 55 1 3 8 0 1 68 3 7 46 38
2022/2023492 27 78 13 19 54 62 1 17 191 6 18 6
2023/2024195 7 23 9 6 3 0 63 0 4 8 34 38
2024/2025215 14 43 22 32 75 29 0 0 0 0 0 0
Totale 1.439